Poland · Delayed Price · Currency is PLN Molecure Statistics
Total Valuation
Molecure has a market cap or net worth of PLN 133.92 million. The enterprise value is 117.04 million.
| Market Cap | 133.92M |
| Enterprise Value | 117.04M |
Important Dates
The last earnings date was Monday, October 27, 2025.
| Earnings Date | Oct 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Molecure has 20.60 million shares outstanding. The number of shares has increased by 36.13% in one year.
| Current Share Class | 20.60M |
| Shares Outstanding | 20.60M |
| Shares Change (YoY) | +36.13% |
| Shares Change (QoQ) | -19.11% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 11.16% |
| Float | 19.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.19 |
| PB Ratio | 1.50 |
| P/TBV Ratio | 5.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.79 |
| EV / Sales | 20.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.21 |
Financial Position
The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.93 |
| Quick Ratio | 5.93 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | -447.22 |
Financial Efficiency
Return on equity (ROE) is -28.81% and return on invested capital (ROIC) is -17.55%.
| Return on Equity (ROE) | -28.81% |
| Return on Assets (ROA) | -17.15% |
| Return on Invested Capital (ROIC) | -17.55% |
| Return on Capital Employed (ROCE) | -27.25% |
| Revenue Per Employee | 62,784 |
| Profits Per Employee | -265,426 |
| Employee Count | 102 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.61% in the last 52 weeks. The beta is 0.82, so Molecure's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -34.61% |
| 50-Day Moving Average | 7.37 |
| 200-Day Moving Average | 7.78 |
| Relative Strength Index (RSI) | 22.76 |
| Average Volume (20 Days) | 17,589 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Molecure had revenue of PLN 5.78 million and -24.42 million in losses. Loss per share was -1.07.
| Revenue | 5.78M |
| Gross Profit | 3.30M |
| Operating Income | -25.37M |
| Pretax Income | -24.42M |
| Net Income | -24.42M |
| EBITDA | -25.93M |
| EBIT | -25.37M |
| Loss Per Share | -1.07 |
Balance Sheet
The company has 22.46 million in cash and 5.58 million in debt, giving a net cash position of 16.88 million or 0.82 per share.
| Cash & Cash Equivalents | 22.46M |
| Total Debt | 5.58M |
| Net Cash | 16.88M |
| Net Cash Per Share | 0.82 |
| Equity (Book Value) | 89.43M |
| Book Value Per Share | 5.26 |
| Working Capital | 19.97M |
Cash Flow
In the last 12 months, operating cash flow was -52.96 million and capital expenditures -39,932, giving a free cash flow of -53.00 million.
| Operating Cash Flow | -52.96M |
| Capital Expenditures | -39,932 |
| Free Cash Flow | -53.00M |
| FCF Per Share | -2.57 |
Margins
| Gross Margin | 57.06% |
| Operating Margin | -439.20% |
| Pretax Margin | -422.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Molecure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.13% |
| Shareholder Yield | -36.13% |
| Earnings Yield | -18.23% |
| FCF Yield | -39.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |